Multifunctional Nanotherapeutics with Long-Acting Release against Macular Degeneration by Minimally Invasive Administration-Reference-Cited by-同舟云学术

Multifunctional Nanotherapeutics with Long-Acting Release against Macular Degeneration by Minimally Invasive Administration

Published:2024-07-17 Issue: Volume: Page:
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Chang Wanwan¹²,Lv Xinying²,Zhu Jiafei²,Shen Jing-Jing²,Yao Jing³^ORCID,Liu Zhuang¹²^ORCID,Chen Qian²^ORCID

Affiliation:

1. School of Pharmacy, Faculty of Medicine & Macao Institute of Materials Science and Engineering, Macau University of Science and Technology, Macau SAR 999078, China

2. Institute of Functional Nano & Soft Materials (FUNSOM), Soochow University, Suzhou, Jiangsu 215127, China

3. Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China

Funder

Collaborative Innovation Center of Suzhou Nano Science and Technology

Ministry of Science and Technology of the People's Republic of China

Fundo para o Desenvolvimento das Ci?ncias e da Tecnologia

National Natural Science Foundation of China

Higher Education Discipline Innovation Project

Suzhou Key Laboratory of Nanotechnology and Biomedicine

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.4c04494

Reference45 articles.

1. World Report on Vision 2019; World Health Organization, 2019.

2. Age-related macular degeneration

3. Nanodiagnostics and Nanotherapeutics for age-related macular degeneration

4. Long-acting intraocular Delivery strategies for biological therapy of age-related macular degeneration

5. Recent advances and future prospects: Current status and challenges of the intraocular injection of drugs for vitreoretinal diseases